Elevated factor VIII levels and risk of venous thrombosis

Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: the ARIC Study

(2012) M. Campos et al.   BLOOD

Persistent high factor VIII activity leading to increased thrombin generation – A prospective cohort study

(2012) J.K. Ryland et al.   THROMBOSIS RESEARCH

Procoagulant activity induced by vascular injury determines contribution of elevated factor VIII to thrombosis and thrombus stability in mice

(2011) K. R. Machlus et al.   BLOOD

Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels

(2011) Guillemette Antoni et al.   BMC Medical Genetics

High Plasma Level of Factor VIII

(2011) Satoshi Ota et al.   CIRCULATION JOURNAL

The acute phase reaction explains only a part of initially elevated factor VIII:C levels: A prospective cohort study in patients with venous thrombosis

(2011) Vladimir Tichelaar et al.   THROMBOSIS RESEARCH

Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis

(2010) N. L. Smith et al.   BLOOD

Clinical guidelines for testing for heritable thrombophilia

(2010) Trevor Baglin et al.   BRITISH JOURNAL OF HAEMATOLOGY

Novel Associations of Multiple Genetic Loci With Plasma Levels of Factor VII, Factor VIII, and von Willebrand Factor

(2010) Nicholas L. Smith et al.   CIRCULATION

Influence of anticoagulant therapy with vitamin K antagonists on plasma levels of coagulation factor VIII

(2010) Serena Maria Passamonti et al.   THROMBOSIS RESEARCH

High Factor VIII Levels Independently Predict Venous Thromboembolism in Cancer Patients

(2009) R. Vormittag et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Expression of terminal  2-6-linked sialic acid on von Willebrand factor specifically enhances proteolysis by ADAMTS13

(2009) R. T. McGrath et al.   BLOOD

Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance

(2009) V. TERRAUBE et al.   HAEMOPHILIA

6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII

(2008) L. Eischer et al.   ANNALS OF HEMATOLOGY

Advances in understanding pathogenic mechanisms of thrombophilic disorders

(2008) B. Dahlback   BLOOD

A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor

(2008) L. Gallinaro et al.   BLOOD

Aquaporin 2 gene variations, risk of venous thrombosis and plasma levels of von Willebrand factor and factor VIII

(2008) A. Y. Nossent et al.   HAEMATOLOGICA

The disappearing act of factor VIII

(2008) P. J. LENTING et al.   HAEMOPHILIA

N-linked glycosylation of VWF modulates its interaction with ADAMTS13

(2007) T. A. J. McKinnon et al.   BLOOD